Akshay Muralidhara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Akshay Muralidhara has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Imrankhan Nizam
Department of Pharmaceutics, JSS College of Pharmacy, JSS AHER, Ooty, Nilgiris, Tamil Nadu, India
1 shared publication - Jawahar Natarajan
Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Nilgiris, Ooty 643001, Tamil Nadu, India
1 shared publication - Jey Kumar Pachiyappan
Australian Plastic Research and Innovation Lab (APRIL), Global Innovative Centre for Advanced Nanomaterials (GICAN), NHMRC Healthy Environment and Lives (HEAL), College of Engineering, Science and Environment, The University of Newcastle, NSW, Australia; Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris, Tamil Nadu, India
1 shared publication - Roshan P. Rao
Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris, India
1 shared publication - S. Selvamuthukumar
Department of Pharmacy, Annamalai University, Annamalai Nagar, Chidambaram, India
1 shared publication - Samanwita Khanra
Department of Pharmaceutics, JSS College of Pharmacy, Ooty, Tamilnadu. JSS Academy of Higher Education & Research, Ooty, India
1 shared publication
Latest Publications
- 4 October 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26 (8) , 1-24
Advances in Pharmaceutical Cocrystals and Nano-Cocrystals: Strategies for Enhancing Solubility and Translating to Clinical Use
Poor oral bioavailability in most modern pharmaceuticals is primarily caused by poor aqueous solubility. Most NCEs (New Chemical Entities) and nearly 40% o
- 4 October 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 26 (8) , 1-24
Advances in Pharmaceutical Cocrystals and Nano-Cocrystals: Strategies for Enhancing Solubility and Translating to Clinical Use
Poor oral bioavailability in most modern pharmaceuticals is primarily caused by poor aqueous solubility. Most NCEs (New Chemical Entities) and nearly 40% o